Authors: GAGNON RF LECLERC J YARED K LIBERMAN AS KHURANA R GUIMOND MC VASILEVSKY M

Citation: Rf. Gagnon et al., SAFE AND EFFECTIVE ANTICOAGULATION WITH ENOXAPARIN DURING HEMODIALYSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 806-806

Authors: GAGNON RF JONASCH E VASILEVSKY M BROX AG

Citation: Rf. Gagnon et al., ABSENCE OF SIGNIFICANT ANEMIA IN 2 DIALYSIS PATIENTS WITHOUT ERYTHROPOIETIN TREATMENT AND BLOOD-TRANSFUSIONS - POSSIBLE ROLE OF INSULIN-LIKE GROWTH-FACTOR-I IN THE MAINTENANCE OF ERYTHROPOIESIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1150-1150

Authors: KHURANA R GAGNON RF CIANFLONE K LECLERC J VASILEVSKY M

Citation: R. Khurana et al., INTRADIALYTIC CHANGES IN CIRCULATING LIPIDS WITH ANTICOAGULATION BY THE LOW-MOLECULAR-WEIGHT HEPARIN ENOXAPARIN, Journal of the American Society of Nephrology, 6(3), 1995, pp. 494-494

Authors: JONASCH E BROX AG GAGNON RF VASILEVSKY M

Citation: E. Jonasch et al., INSULIN-LIKE GROWTH-FACTOR-I (IGF-1), IGF1 BINDING-PROTEINS (BP1, BP3) AND ERYTHROPOIETIN (EPO) SERUM LEVELS IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 579-579

Authors: LAPLANTE LE ANG AA BOURGOUIN PA COHANIM M HERZENBERG M MCMURDO M SAVARD C SEXTON F SHAVER CS SHWARTZ I LALONDE J GIBB RA GIOVANNINI AA IRVING DW VASILEVSKY M FRIED JA AMIES DR JAW M DUNHAM PB MORSE JWI PARENT R JOHNSON TE LAPOINTE G DUMAS S HALPENNY RL POPOWICH KR

Citation: Le. Laplante et al., ENALAPRIL AND ENALAPRIL-HYDROCHLOROTHIAZIDE IN THE TREATMENT OF ESSENTIAL-HYPERTENSION, Clinical therapeutics, 15(2), 1993, pp. 364-373